UMB’s Megan Meyer and Andrew Coop are featured for leading an innovative, interprofessional initiative that prepares future clinicians for ethical, evidence-based psychedelic-assisted therapy.
The Multidisciplinary Association for Psychedelic Studies (MAPS) recently highlighted the University of Maryland, Baltimore’s leadership in psychedelic education and training, featuring Megan Meyer, MSW, PhD, of the School of Social Work, and Andrew Coop, PhD, of the School of Pharmacy.
In the Bulletin piece, Meyer and Coop describe UMB’s proactive, interprofessional approach to preparing the health care workforce for psychedelic‑assisted therapy, including collaborative initiatives that bring together social work, pharmacy, nursing, and other disciplines. Their work underscores UMB’s commitment to grounding this emerging field in science, ethics, equity, and culturally responsive care.